Therefore, these data suggest that HES1 positively modulated GLUT1 expression in CRC cells through IGF2BP2 recognizing and binding the m6A site in the GLUT1 mRNA and enhancing its stability. Here, SLC2A1 is linked to colorectal carcinoma.